US Stock MarketDetailed Quotes

EXAS Exact Sciences

Watchlist
  • 61.690
  • +1.590+2.65%
Close Nov 27 16:00 ET
  • 60.260
  • -1.430-2.32%
Post 20:02 ET
11.42BMarket Cap-53181P/E (TTM)

Exact Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
469.43%138.72M
6.61%107.07M
-115.39%-82.31M
169.83%156.12M
33.65%69.55M
159.52%24.36M
264.86%100.42M
78.01%-38.22M
-118.67%-223.56M
311.77%52.04M
Net income from continuing operations
-4,915.62%-38.24M
80.49%-15.81M
-48.65%-110.23M
67.26%-204.15M
61.04%-49.77M
100.53%794K
51.21%-81.03M
59.02%-74.15M
-4.68%-623.51M
42.09%-127.75M
Operating gains losses
-88.10%657K
-767.26%-11.56M
133.06%2.42M
-141.18%-14.42M
-221.98%-14.36M
--5.52M
--1.73M
-2,378.82%-7.32M
218.93%35.02M
9,170.87%11.77M
Depreciation and amortization
4.82%54.77M
5.07%53M
8.44%53.94M
4.58%206.61M
9.48%54.17M
7.59%52.25M
-2.74%50.44M
4.40%49.74M
9.54%197.56M
9.65%49.48M
Deferred tax
58.15%-398K
172.67%428K
42.51%1.8M
91.98%-955K
73.54%-676K
78.42%-951K
80.55%-589K
165.95%1.26M
95.30%-11.9M
42.62%-2.56M
Other non cash items
114.23%10.04M
-198.27%-12.95M
11,245.76%13.15M
-264.90%-62.55M
-173.49%-5.05M
-1,410.76%-70.56M
211.81%13.17M
99.33%-118K
-108.36%-17.14M
49.84%6.87M
Change In working capital
280.80%44.43M
-46.26%29.24M
-90.36%-108.21M
98.70%-342K
-61.01%26.66M
-24.83%-24.57M
5,610.18%54.42M
25.21%-56.84M
-123.74%-26.38M
-27.17%68.36M
-Change in receivables
97.43%-509K
-572.78%-23.37M
-47.58%-37.54M
-171.07%-43.42M
-109.39%-3.11M
-643.77%-19.81M
-74.80%4.94M
-330.80%-25.43M
142.89%61.09M
-15.48%33.12M
-Change in inventory
-1,670.17%-9.61M
117.32%1.16M
81.72%-1.07M
41.88%-7.69M
252.69%5.38M
-214.80%-543K
-202.80%-6.7M
26.83%-5.83M
-43.49%-13.23M
56.63%-3.53M
-Change in payables and accrued expense
2,308.71%56.12M
-33.45%35.65M
-1,010.96%-53.52M
258.59%82.75M
-14.62%31.67M
123.47%2.33M
503.06%53.57M
92.71%-4.82M
-130.73%-52.18M
-64.83%37.09M
-Change in other current assets
-38.72%3.64M
132.74%9.31M
51.65%-6.59M
-13,730.95%-11.62M
-264.67%-7.93M
907.89%5.94M
62.98%4M
-105.80%-13.62M
---84K
--4.82M
-Change in other current liabilities
58.23%-5.21M
567.31%6.49M
-33.10%-9.51M
7.29%-20.37M
120.59%647K
-82.79%-12.48M
75.23%-1.39M
-11.75%-7.14M
-31.68%-21.97M
35.23%-3.14M
Cash from discontinued investing activities
Operating cash flow
469.43%138.72M
6.61%107.07M
-115.39%-82.31M
169.83%156.12M
33.65%69.55M
159.52%24.36M
264.86%100.42M
78.01%-38.22M
-118.67%-223.56M
311.77%52.04M
Investing cash flow
Cash flow from continuing investing activities
-147.86%-81.72M
-321.33%-147.13M
-306.70%-171.44M
-32.93%49.68M
-14.80%-66.77M
-150.72%-32.97M
206.91%66.47M
82.04%82.94M
106.84%74.07M
-174.15%-58.16M
Net PPE purchase and sale
-3.86%-26.16M
-3.30%-35.87M
-28.23%-37.65M
42.09%-124.19M
52.08%-34.92M
43.57%-25.19M
45.17%-34.72M
12.68%-29.36M
-57.96%-214.46M
-22.70%-72.88M
Net business purchase and sale
----
----
46.38%-237K
-19.94%-68.98M
39.50%-18.98M
----
----
62.29%-442K
88.89%-57.51M
64.63%-31.37M
Net investment purchase and sale
-125.11%-10.54M
-210.12%-111.5M
-218.28%-133.35M
-24.41%243.1M
-127.62%-12.87M
-50.51%41.97M
-7.82%101.25M
40.29%112.74M
186.98%321.59M
-79.48%46.58M
Net other investing changes
-18,108.00%-45.02M
--0
---205K
-101.02%-250K
--0
-99.00%250K
----
----
141.57%24.45M
0.00%-500K
Cash from discontinued investing activities
Investing cash flow
-147.86%-81.72M
-321.33%-147.13M
-306.70%-171.44M
-32.93%49.68M
-14.80%-66.77M
-150.72%-32.97M
206.91%66.47M
82.04%82.94M
106.84%74.07M
-174.15%-58.16M
Financing cash flow
Cash flow from continuing financing activities
-345.65%-226K
1,300.18%224.6M
-102.25%-3M
108.89%159.77M
-0.65%10.04M
-60.85%92K
-74.70%16.04M
4,784.68%133.6M
802.80%76.49M
182.84%10.1M
Net issuance payments of debt
--0
--216.75M
--0
175.95%137.98M
--0
--0
--0
--137.98M
310.54%50M
--0
Proceeds from stock option exercised by employees
97.96%2.13M
13.08%19.45M
-246.06%-1.41M
-1.48%31.54M
16.96%12.3M
14.45%1.08M
5.68%17.2M
-77.49%964K
-14.64%32.02M
-13.04%10.52M
Net other financing activities
-139.39%-2.36M
-903.64%-11.59M
70.17%-1.59M
-76.33%-9.75M
-443.65%-2.27M
-39.52%-985K
59.62%-1.16M
-245.44%-5.34M
-4.62%-5.53M
23.35%-417K
Cash from discontinued financing activities
Financing cash flow
-345.65%-226K
1,300.18%224.6M
-102.25%-3M
108.89%159.77M
-0.65%10.04M
-60.85%92K
-74.70%16.04M
4,784.68%133.6M
802.80%76.49M
182.84%10.1M
Net cash flow
Beginning cash position
-11.35%536.02M
-16.57%351.78M
151.11%609.68M
-23.11%242.79M
152.50%594.91M
182.92%604.66M
121.84%421.66M
-23.11%242.79M
-78.83%315.77M
-14.04%235.6M
Current changes in cash
766.71%56.78M
0.87%184.54M
-243.98%-256.75M
600.72%365.56M
222.00%12.82M
-135.03%-8.52M
657.35%182.94M
242.14%178.32M
93.79%-73.01M
-90.45%3.98M
Effect of exchange rate changes
251.66%1.87M
-618.64%-306K
-307.27%-1.14M
4,303.33%1.32M
-39.27%1.95M
49.16%-1.24M
111.57%59K
332.07%550K
30.43%30K
13,839.13%3.21M
End cash Position
-0.04%594.67M
-11.35%536.02M
-16.57%351.78M
151.11%609.68M
151.11%609.68M
152.50%594.91M
182.92%604.66M
121.84%421.66M
-23.11%242.79M
-23.11%242.79M
Free cash flow
13,727.24%112.56M
8.36%71.2M
-77.52%-119.96M
107.29%31.93M
266.16%34.63M
99.03%-826K
152.88%65.7M
67.41%-67.58M
-84.04%-438.02M
75.18%-20.84M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 469.43%138.72M6.61%107.07M-115.39%-82.31M169.83%156.12M33.65%69.55M159.52%24.36M264.86%100.42M78.01%-38.22M-118.67%-223.56M311.77%52.04M
Net income from continuing operations -4,915.62%-38.24M80.49%-15.81M-48.65%-110.23M67.26%-204.15M61.04%-49.77M100.53%794K51.21%-81.03M59.02%-74.15M-4.68%-623.51M42.09%-127.75M
Operating gains losses -88.10%657K-767.26%-11.56M133.06%2.42M-141.18%-14.42M-221.98%-14.36M--5.52M--1.73M-2,378.82%-7.32M218.93%35.02M9,170.87%11.77M
Depreciation and amortization 4.82%54.77M5.07%53M8.44%53.94M4.58%206.61M9.48%54.17M7.59%52.25M-2.74%50.44M4.40%49.74M9.54%197.56M9.65%49.48M
Deferred tax 58.15%-398K172.67%428K42.51%1.8M91.98%-955K73.54%-676K78.42%-951K80.55%-589K165.95%1.26M95.30%-11.9M42.62%-2.56M
Other non cash items 114.23%10.04M-198.27%-12.95M11,245.76%13.15M-264.90%-62.55M-173.49%-5.05M-1,410.76%-70.56M211.81%13.17M99.33%-118K-108.36%-17.14M49.84%6.87M
Change In working capital 280.80%44.43M-46.26%29.24M-90.36%-108.21M98.70%-342K-61.01%26.66M-24.83%-24.57M5,610.18%54.42M25.21%-56.84M-123.74%-26.38M-27.17%68.36M
-Change in receivables 97.43%-509K-572.78%-23.37M-47.58%-37.54M-171.07%-43.42M-109.39%-3.11M-643.77%-19.81M-74.80%4.94M-330.80%-25.43M142.89%61.09M-15.48%33.12M
-Change in inventory -1,670.17%-9.61M117.32%1.16M81.72%-1.07M41.88%-7.69M252.69%5.38M-214.80%-543K-202.80%-6.7M26.83%-5.83M-43.49%-13.23M56.63%-3.53M
-Change in payables and accrued expense 2,308.71%56.12M-33.45%35.65M-1,010.96%-53.52M258.59%82.75M-14.62%31.67M123.47%2.33M503.06%53.57M92.71%-4.82M-130.73%-52.18M-64.83%37.09M
-Change in other current assets -38.72%3.64M132.74%9.31M51.65%-6.59M-13,730.95%-11.62M-264.67%-7.93M907.89%5.94M62.98%4M-105.80%-13.62M---84K--4.82M
-Change in other current liabilities 58.23%-5.21M567.31%6.49M-33.10%-9.51M7.29%-20.37M120.59%647K-82.79%-12.48M75.23%-1.39M-11.75%-7.14M-31.68%-21.97M35.23%-3.14M
Cash from discontinued investing activities
Operating cash flow 469.43%138.72M6.61%107.07M-115.39%-82.31M169.83%156.12M33.65%69.55M159.52%24.36M264.86%100.42M78.01%-38.22M-118.67%-223.56M311.77%52.04M
Investing cash flow
Cash flow from continuing investing activities -147.86%-81.72M-321.33%-147.13M-306.70%-171.44M-32.93%49.68M-14.80%-66.77M-150.72%-32.97M206.91%66.47M82.04%82.94M106.84%74.07M-174.15%-58.16M
Net PPE purchase and sale -3.86%-26.16M-3.30%-35.87M-28.23%-37.65M42.09%-124.19M52.08%-34.92M43.57%-25.19M45.17%-34.72M12.68%-29.36M-57.96%-214.46M-22.70%-72.88M
Net business purchase and sale --------46.38%-237K-19.94%-68.98M39.50%-18.98M--------62.29%-442K88.89%-57.51M64.63%-31.37M
Net investment purchase and sale -125.11%-10.54M-210.12%-111.5M-218.28%-133.35M-24.41%243.1M-127.62%-12.87M-50.51%41.97M-7.82%101.25M40.29%112.74M186.98%321.59M-79.48%46.58M
Net other investing changes -18,108.00%-45.02M--0---205K-101.02%-250K--0-99.00%250K--------141.57%24.45M0.00%-500K
Cash from discontinued investing activities
Investing cash flow -147.86%-81.72M-321.33%-147.13M-306.70%-171.44M-32.93%49.68M-14.80%-66.77M-150.72%-32.97M206.91%66.47M82.04%82.94M106.84%74.07M-174.15%-58.16M
Financing cash flow
Cash flow from continuing financing activities -345.65%-226K1,300.18%224.6M-102.25%-3M108.89%159.77M-0.65%10.04M-60.85%92K-74.70%16.04M4,784.68%133.6M802.80%76.49M182.84%10.1M
Net issuance payments of debt --0--216.75M--0175.95%137.98M--0--0--0--137.98M310.54%50M--0
Proceeds from stock option exercised by employees 97.96%2.13M13.08%19.45M-246.06%-1.41M-1.48%31.54M16.96%12.3M14.45%1.08M5.68%17.2M-77.49%964K-14.64%32.02M-13.04%10.52M
Net other financing activities -139.39%-2.36M-903.64%-11.59M70.17%-1.59M-76.33%-9.75M-443.65%-2.27M-39.52%-985K59.62%-1.16M-245.44%-5.34M-4.62%-5.53M23.35%-417K
Cash from discontinued financing activities
Financing cash flow -345.65%-226K1,300.18%224.6M-102.25%-3M108.89%159.77M-0.65%10.04M-60.85%92K-74.70%16.04M4,784.68%133.6M802.80%76.49M182.84%10.1M
Net cash flow
Beginning cash position -11.35%536.02M-16.57%351.78M151.11%609.68M-23.11%242.79M152.50%594.91M182.92%604.66M121.84%421.66M-23.11%242.79M-78.83%315.77M-14.04%235.6M
Current changes in cash 766.71%56.78M0.87%184.54M-243.98%-256.75M600.72%365.56M222.00%12.82M-135.03%-8.52M657.35%182.94M242.14%178.32M93.79%-73.01M-90.45%3.98M
Effect of exchange rate changes 251.66%1.87M-618.64%-306K-307.27%-1.14M4,303.33%1.32M-39.27%1.95M49.16%-1.24M111.57%59K332.07%550K30.43%30K13,839.13%3.21M
End cash Position -0.04%594.67M-11.35%536.02M-16.57%351.78M151.11%609.68M151.11%609.68M152.50%594.91M182.92%604.66M121.84%421.66M-23.11%242.79M-23.11%242.79M
Free cash flow 13,727.24%112.56M8.36%71.2M-77.52%-119.96M107.29%31.93M266.16%34.63M99.03%-826K152.88%65.7M67.41%-67.58M-84.04%-438.02M75.18%-20.84M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Cancer Research
Cancer Research
Intraday+1.05%